Stellar Biotechnologies Presents Preclinical Poster on Clostridium Difficile Research at Society for Glycobiology Meeting
PORT HUENEME, CA -- (Marketwired) -- 12/04/15 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT) (TSX VENTURE: KLH), announced today the presentation of a preclinical poster relating to its research on …